ArticleBioscience reports2016

Up-regulation of KIF14 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in cervical cancer.

Wenjing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.